Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 20/20 | 0.55 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.51 |
| ▸ | RORA | P35398 | 1/20 | 0.51 |
| ▸ | RORB | Q92753 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24840211 | 0.91 | RORC (0.59) | RORCNR1I2RORARORB | |
| SCHEMBL24840212 | 0.91 | RORC (0.49) | RORCNR1I2RORARORB | |
| SCHEMBL24286796 | 0.87 | RORC (0.57) | RORCNR1I2RORARORB | |
| SCHEMBL24840240 | 0.87 | RORC (0.57) | RORCNR1I2RORARORB | |
| SCHEMBL24839969 | 0.87 | RORC (0.57) | RORCNR1I2RORARORB | |
| SCHEMBL24840258 | 0.87 | RORC (0.57) | RORCNR1I2RORARORB | |
| SCHEMBL30110809 | 0.86 | RORC (0.74) | RORCNR1I2RORARORB | |
| SCHEMBL18312797 | 0.86 | RORC (0.74) | RORCNR1I2RORARORB | |
| SCHEMBL24839745 | 0.85 | RORC (0.55) | RORCNR1I2RORARORB | |
| SCHEMBL24840251 | 0.85 | RORC (0.53) | RORCNR1I2RORARORB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023274396-A1 | BENZAZEPINE HETEROCYCLIC COMPOUND AND APPLICATION THEREOF IN MEDICINE | 广东东阳光药业有限公司 | 2023-01-05 | — | — | WO | disclosed |
| EP-3307738-B1 | ARYL DIHYDRO-2H-BENZO[B][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE | UNIV MICHIGAN REGENTS (US) | 2022-04-20 | — | — | EP | disclosed |